Medicare Enrolled
Dr. Fateh Ahmed, MD
Pulmonary Disease · Toledo, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ahmed from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahmed?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ahmed
Dr. Fateh Ahmed is a pulmonary disease specialist in Toledo, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Ahmed performed 3,394 Medicare services across 1,913 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ahmed received a total of $51,050 from 61 pharmaceutical and/or device companies across 1187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahmed is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 2% volume in OH
$51,050 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,394
Medicare services
Top 2% in OH for pulmonary disease
1,913
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~162 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,168 | $91 | $205 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
762 | $88 | $208 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
340 | $61 | $142 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
231 | $130 | $398 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
169 | $60 | $141 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
136 | $26 | $114 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
133 | $40 | $101 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
124 | $37 | $99 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
94 | $164 | $436 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $107 | $320 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
37 | $94 | $253 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $72 | $209 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
32 | $67 | $351 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
30 | $90 | $243 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
14 | $100 | $1,012 |
| Arterial line insertion A tube is inserted into an artery through the skin to allow for blood sampling or infusion. |
14 | $34 | $121 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
12 | $65 | $647 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
0.0% medium
99.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$51,050
Total received (2018-2024)
Avg $7,293/year across 7 years
Top 6% in OH for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
1,187
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27,346 (53.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,994 (35.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,710 (11.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,284
2023
$3,873
2022
$5,967
2021
$15,670
2020
$7,914
2019
$7,767
2018
$6,576
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$710
Axsome Therapeutics, Inc.
$313
GlaxoSmithKline, LLC.
$243
Baxter Healthcare
$240
Actelion Pharmaceuticals US, Inc.
$205
HARMONY BIOSCIENCES LLC
$192
Regeneron Healthcare Solutions, Inc.
$172
Mylan Specialty L.P.
$168
Takeda Pharmaceuticals U.S.A., Inc.
$152
GENZYME CORPORATION
$133
Harmony Biosciences Llc
$116
Avadel CNS Pharmaceuticals, LLC
$109
Grifols USA, LLC
$94
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
United Therapeutics Corporation
$81
JAZZ PHARMACEUTICALS INC.
$77
Amgen Inc.
$73
PFIZER INC.
$40
ANI Pharmaceuticals, Inc.
$22
Pulmonx Corporation
$21
INOGEN, INC.
$17
Insmed, Inc.
$17
Top 3 companies account for 38.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$33,580
GlaxoSmithKline, LLC.
$2,265
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,914
United Therapeutics Corporation
$1,192
JAZZ PHARMACEUTICALS INC.
$977
Mylan Specialty L.P.
$931
Baxter Healthcare
$821
Axsome Therapeutics, Inc.
$767
Grifols USA, LLC
$728
GENZYME CORPORATION
$711
Takeda Pharmaceuticals U.S.A., Inc.
$597
Actelion Pharmaceuticals US, Inc.
$484
Regeneron Healthcare Solutions, Inc.
$471
Genentech USA, Inc.
$449
Jazz Pharmaceuticals Inc.
$379
HARMONY BIOSCIENCES LLC
$343
Astellas Pharma US Inc
$333
Sunovion Pharmaceuticals Inc.
$320
Amgen Inc.
$296
Harmony Biosciences LLC
$284
Electromed, Inc.
$243
Insmed, Inc.
$215
Pulmonx Corporation
$180
Merck Sharp & Dohme Corporation
$170
SANOFI-AVENTIS U.S. LLC
$156
Avadel CNS Pharmaceuticals, LLC
$154
Teva Pharmaceuticals USA, Inc.
$144
Circassia Pharmaceuticals Inc
$137
Inspire Medical Systems, Inc.
$131
Bayer HealthCare Pharmaceuticals Inc.
$125
Philips Electronics North America Corporation
$118
PFIZER INC.
$118
Harmony Biosciences Llc
$116
Janssen Pharmaceuticals, Inc
$109
Advanced Respiratory, Inc
$101
CSL Behring
$101
Merck Sharp & Dohme LLC
$97
Mallinckrodt LLC
$76
Shire North American Group Inc
$75
Paratek Pharmaceuticals, Inc.
$65
Mallinckrodt Hospital Products Inc.
$57
ADVANCED RESPIRATORY, INC
$51
TETRAPHASE PHARMACEUTICALS, INC.
$48
Inogen, Inc.
$41
Phadia US Inc.
$35
Eisai Inc.
$35
ARBOR PHARMACEUTICALS, INC.
$34
IDORSIA PHARMACEUTICALS US INC
$33
Novartis Pharmaceuticals Corporation
$32
E.R. Squibb & Sons, L.L.C.
$28
Mallinckrodt Enterprises LLC
$23
ANI Pharmaceuticals, Inc.
$22
EKOS Corporation
$19
MAYNE PHARMA INC.
$18
INOGEN, INC.
$17
Allergan Inc.
$16
Fisher & Paykel Healthcare Inc
$16
Gilead Sciences, Inc.
$15
Allergan, Inc.
$13
Mayne Pharma Inc.
$13
Covis Pharma GmBH
$12
Top 3 companies account for 74.0% of all-time payments
Associated products mentioned in payments ›
(8744) Trilogy Evo · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · CRESEMBA · DORYX · DUPIXENT · Dayvigo · EKOSONIC · ELIQUIS · Esbriet · FARXIGA · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Horizant · INOGEN · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · ImmunoCAP · InogenOne · Inspire Upper Airway Stimulation System · KEYTRUDA · LEXISCAN · LONHALA MAGNAIR · LUMRYZ · MYCAMINE · NIOX VERO · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Obstructive Sleep Apnea Device or Hospital Respiratory Equipment · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · QVAR · S&RC Und · S&RC Undivided · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · WAKIX · Wakix · XARELTO · XERAVA · XOLAIR · XYREM · XYWAV · Xerava · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (54%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for pulmonary disease in OH.
Geographic Context
Pulmonary diseases within 10 mi
27
Per 100K population
6.3
County median income
$60,095
Nearest hospital
PROMEDICA TOLEDO HOSPITAL
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ahmed is a clinical cardiology specialist, with above-average Medicare volume (top 2% in OH), with speaking/promotional industry engagement in the top 6% of OH peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ahmed experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Ahmed performed 1,168 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ahmed receive payments from pharmaceutical companies?
Yes. Dr. Ahmed received a total of $51,050 from 61 companies across 1,187 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahmed's costs compare to other pulmonary diseases in Toledo?
Dr. Ahmed's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahmed) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Toledo
Browse pulmonary diseases in Toledo ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in OH
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in OH
Which OH pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology